RARA CRAFT DATABASE for FDA Medical Devices
510(k)K233985

FDA DEVICE FACTS

TRIUX™ neo (NM27000N ); MEGreview (SW26241N-B)

Megin OY

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMay 15, 2024PRODUCT CODEOLX

Indications for use

TRIUX™ neo The TRIUX™ neo non-invasively measures the magnetoencephalographic (MEG) signals (and, optionally, electroencephalographic (EEG) signals) produced by electrically active tissue of the brain. These signals are recorded by a computerized data acquisition system, displayed and may then be interpreted by trained physicians to help localize these active areas. The locations may then be correlated with anatomical information of the brain. MEG is routinely used to identify the locations of visual, auditory, somatosensory, and motor cortex in the brain when used in conjunction with evoked response stimulators. MEG is also used to non-invasively locate regions of epileptic activity within the brain. The localization information provided by MEG may be used, in conjunction with other diagnostic data, in neurosurgical planning.

TRIUX™ neo may be used for patients of all ages as appropriate for magnetoencephalography.

MEGreview™ MEGreview™ is used for detection and localization of epileptic spontaneous brain activity. In addition, MEGreview™ may be used for localization of eloquent cortex, such as visual, auditory, somatosensory, and motor functions. Results interpreted by a trained clinician in conjunction with other imaging modalities can contribute to presurgical evaluation.

MEGreview™ is intended for patients of all ages as appropriate for magnetoencephalography.

COMPARISON OF INDICATIONS FOR USE

TRIUX™ neo has identical Indications for use as the primary predicate Elekta Neuromag® with MaxFilter 2.1.

MEGreview™ has similar Indications for use as the primary predicate Elekta Neuromag® with MaxFilter 2.1. The predicate device is the whole MEG system including hardware and software for both data acquisition and analysis, and MEGreview™ is the analysis software only. While worded differently, the Indications for use for MEGreview™ is the same as for the analysis software part of the predicate device; source localization of active brain areas (epileptic spontaneous activity or eloquent cortex).

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 17, 2026